Dialysis prescription and kinetics in acute renal failure

W. R. Clark, B. A. Mueller, Michael Kraus, W. L. Macias

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. Finally, recent data suggesting survival in critically ill ARF patients is directly correlated with delivered therapy dose are reviewed. The optimal technique for RRT quantification in ARF remains to be determined.

Original languageEnglish (US)
Pages (from-to)64-71
Number of pages8
JournalAdvances in Renal Replacement Therapy
Volume4
Issue number2 SUPPL. 1
StatePublished - 1997
Externally publishedYes

Fingerprint

Acute Kidney Injury
Renal Replacement Therapy
Chronic Kidney Failure
Prescriptions
Dialysis
Renal Dialysis
Critical Illness
Research Personnel
Morbidity
Survival
Mortality
Therapeutics

Keywords

  • acute renal failure
  • azotemia
  • hemodialysis
  • Hemofiltration
  • hypercatabolism

ASJC Scopus subject areas

  • Nephrology

Cite this

Clark, W. R., Mueller, B. A., Kraus, M., & Macias, W. L. (1997). Dialysis prescription and kinetics in acute renal failure. Advances in Renal Replacement Therapy, 4(2 SUPPL. 1), 64-71.

Dialysis prescription and kinetics in acute renal failure. / Clark, W. R.; Mueller, B. A.; Kraus, Michael; Macias, W. L.

In: Advances in Renal Replacement Therapy, Vol. 4, No. 2 SUPPL. 1, 1997, p. 64-71.

Research output: Contribution to journalArticle

Clark, WR, Mueller, BA, Kraus, M & Macias, WL 1997, 'Dialysis prescription and kinetics in acute renal failure', Advances in Renal Replacement Therapy, vol. 4, no. 2 SUPPL. 1, pp. 64-71.
Clark WR, Mueller BA, Kraus M, Macias WL. Dialysis prescription and kinetics in acute renal failure. Advances in Renal Replacement Therapy. 1997;4(2 SUPPL. 1):64-71.
Clark, W. R. ; Mueller, B. A. ; Kraus, Michael ; Macias, W. L. / Dialysis prescription and kinetics in acute renal failure. In: Advances in Renal Replacement Therapy. 1997 ; Vol. 4, No. 2 SUPPL. 1. pp. 64-71.
@article{b3497d0e599b467383d8a342bdb8c769,
title = "Dialysis prescription and kinetics in acute renal failure",
abstract = "The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. Finally, recent data suggesting survival in critically ill ARF patients is directly correlated with delivered therapy dose are reviewed. The optimal technique for RRT quantification in ARF remains to be determined.",
keywords = "acute renal failure, azotemia, hemodialysis, Hemofiltration, hypercatabolism",
author = "Clark, {W. R.} and Mueller, {B. A.} and Michael Kraus and Macias, {W. L.}",
year = "1997",
language = "English (US)",
volume = "4",
pages = "64--71",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - Dialysis prescription and kinetics in acute renal failure

AU - Clark, W. R.

AU - Mueller, B. A.

AU - Kraus, Michael

AU - Macias, W. L.

PY - 1997

Y1 - 1997

N2 - The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. Finally, recent data suggesting survival in critically ill ARF patients is directly correlated with delivered therapy dose are reviewed. The optimal technique for RRT quantification in ARF remains to be determined.

AB - The recognition that both morbidity and mortality are inversely related to delivered hemodialysis (HD) dose in end-stage renal disease (ESRD) patients has substantially changed clinical practices in the United States. A number of quantification techniques, which differ greatly in complexity and sophistication, are now used in ESRD patients. Investigators recently have attempted to extrapolate some of these ESRD quantification methods to the acute renal failure (ARF) setting. This review focuses on these recent attempts. Both patient-related and renal replacement therapy (RRT)-related differences in ESRD and ARF are discussed. In addition, the potential pitfalls of extrapolating certain ESRD quantification methods to RRT in ARF are discussed. Prescription considerations for both intermittent HD (IHD) and continuous RRT (CRRT) are presented. Finally, recent data suggesting survival in critically ill ARF patients is directly correlated with delivered therapy dose are reviewed. The optimal technique for RRT quantification in ARF remains to be determined.

KW - acute renal failure

KW - azotemia

KW - hemodialysis

KW - Hemofiltration

KW - hypercatabolism

UR - http://www.scopus.com/inward/record.url?scp=0030976756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030976756&partnerID=8YFLogxK

M3 - Article

C2 - 9113242

AN - SCOPUS:0030976756

VL - 4

SP - 64

EP - 71

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 2 SUPPL. 1

ER -